The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.
Ravina Kullar, PharmD, MPH, FIDSA*
Advertisement
Articles by Ravina Kullar, PharmD, MPH, FIDSA*
Advertisement
Latest Updated Articles
- Investigational Treatments for Clostridioides difficile Infection
Published: October 10th 2019 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Infectious Disease Regulatory Watch: December Highlights
2
Protectors vs Police: How Antimicrobial Stewardship Interventions Come Across and How to Change the Narrative
3
Top Infectious Disease News Stories Week of January 10 - January 16
4
Phase 3 Clinical Trial Reporting, Prospective Regulatory Filings to Watch For in 2026
5